Quantcast

Latest Hemostasis Stories

2014-04-02 15:37:00

Discovery could lead to more effective therapies to prevent heart attacks Right now, options are limited for preventing heart attacks. However, the day may come when treatments target the heart attack gene, myeloid related protein-14 (MRP-14, also known as S100A9) and defang its ability to produce heart attack-inducing blood clots, a process referred to as thrombosis. Scientists at Case Western Reserve School of Medicine and University Hospitals Case Medical Center have reached a...

2014-02-04 08:35:29

-Now Direct with Hemostasis and Critical Care Product Lines in All Major Markets Worldwide- BEDFORD, Mass., Feb. 4, 2014 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that they have successfully completed their transition to direct sales, service, support and marketing for their Hemostasis product line in Japan. A multi-faceted team of sales and technical sales representatives, field service engineers and respective managers has been deployed throughout the...

2011-03-03 13:35:00

RESEARCH TRIANGLE PARK, N.C., March 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by...

2011-01-27 12:47:00

ROCKVILLE, Md., Jan. 27, 2011 /PRNewswire/ -- In a study conducted jointly by the US Army Institute of Surgical Research and STB Lifesaving Technologies®, and just published in The Journal of Trauma, STB®'s FAST® (Fibrin Adhesive STat) Dressing was shown to be superior to the most effective available agents for controlling severe arterial bleeding. The study compared currently available agents with the FAST® dressing,...

2010-11-18 17:43:00

SOMERVILLE, N.J., Nov. 18, 2010 /PRNewswire/ -- Ethicon, Inc., a worldwide leader in surgical care, announced today that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human Fibrinogen and Human Thrombin), to aid in stopping soft tissue bleeding during surgery. "Excessive bleeding during surgical procedures is a...

2010-10-27 10:00:00

(Ivanhoe Newswire) -- Platelets are cell fragments that circulate in the blood of mammals.  These big, regularly-shaped cells are chiefly involved in hemostasis, a central factor leading to the formation of blood clots.  If the number of platelets is too low, excessive bleeding can occur (thrombocytopenia).  However, if the number of platelets is too high, blood clots can form (thrombosis). Mortimer Poncz and colleagues, at Children's Hospital of Philadelphia, working with...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related